newsfilter
← Latest News
Business Wire·

Vertex to Announce Third Quarter 2026 Financial Results November 2nd

  • Vertex Pharmaceuticals will report third quarter 2026 financial results on Monday, November 2, 2026, after market close.
  • A conference call & webcast will occur at 4:30 p.m. ET, accessible via phone or the company's "Investors" website section.
  • Participants are advised to register at least 15 minutes prior to the event for a timely connection, with an archived webcast available later.
  • The company holds approved therapies for cystic fibrosis, sickle cell disease, beta thalassemia, acute pain, & acromegaly.
  • Vertex's pipeline includes investigational therapies for conditions such as IgA nephropathy, type 1 diabetes, & myotonic dystrophy type 1.
  • Founded in 1989, the company has global headquarters in Boston & international headquarters in London, with operations across North America, Europe, Australia, Latin America, & the Middle East.
  • Vertex has been recognized as a top employer for 16 consecutive years by Science magazine & is listed among Fortune's 100 Best Companies to Work For.